 |
ibrutinib |
|---|---|
| Trade Name | Imbruvica |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-12-03 00:00:00 |
| Sponsor | Pharmacyclics, LLC;995 E. Arques Avenue;Sunnyvale, California, 94085 |
| |
ibrutinib |
|---|---|
| Trade Name | Imbruvica |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-12-03 00:00:00 |
| Sponsor | Pharmacyclics, LLC;995 E. Arques Avenue;Sunnyvale, California, 94085 |